Journal article
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers The 3M TAVR Study
Abstract
OBJECTIVES: The authors sought to prospectively determine the safety and efficacy of next-day discharge using the Vancouver 3M (Multidisciplinary, Multimodality, but Minimalist) Clinical Pathway.
BACKGROUND: Transfemoral transcatheter aortic valve replacement (TAVR) is an alternative to surgery in high- and intermediate-risk patients; however, hospital stays average at least 6 days in most trials. The Vancouver 3M Clinical Pathway is focused on …
Authors
Wood DA; Lauck SB; Cairns JA; Humphries KH; Cook R; Welsh R; Leipsic J; Genereux P; Moss R; Jue J
Journal
JACC Cardiovascular Interventions, Vol. 12, No. 5, pp. 459–469
Publisher
Elsevier
Publication Date
March 2019
DOI
10.1016/j.jcin.2018.12.020
ISSN
1936-8798
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAged, 80 and overAortic ValveCanadaCatheterization, PeripheralCritical PathwaysFemaleFemoral ArteryHeart Valve ProsthesisHospitals, High-VolumeHospitals, Low-VolumeHumansLength of StayMalePatient DischargePatient ReadmissionPostoperative ComplicationsProspective StudiesProsthesis DesignPuncturesRisk AssessmentRisk FactorsTime FactorsTranscatheter Aortic Valve ReplacementTreatment OutcomeUnited States